PAUL SAKUMA, ASSOCIATED PRESS CHAD RACHMAN, ASSOCIATED PRESS GREGORY BULL, ASSOCIATED PRESS JULIE JACOBSON, ASSOCIATED PRESS JULIE JACOBSON, ASSOCIATED PRESS ADAM ROUNTREE, ASSOCIATED PRESS JULIE JACOBSON,, ASSOCIATED PRESS MIKE ROEMER, ASSOCIATED PRESS MIKE ROEMER, ASSOCIATED PRESS MORRY GASH, ASSOCIATED PRESS MIKE ROEMER, ASSOCIATED PRESS MORRY GASH, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL MORRY GASH, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL DAVE MARTIN, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL TOM LYNN, ASSOCIATED PRESS MIKE ROEMER, ASSOCIATED PRESS MIKE ROEMER, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL PAUL SANCYA, ASSOCIATED PRESS PAUL SANCYA, ASSOCIATED PRESS PAUL SANCYA, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL MATT LUDTKE, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL JOHN BAZEMORE, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL MIKE ROEMER, ASSOCIATED PRESS DAVID GOLDMAN, ASSOCIATED PRESS STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS, STATE JOURNAL STEVE APPS STATE JOURNAL STEVE APPS, STATE JOURNAL ARCHIVES STEVE APPS, STATE JOURNAL ARCHIVES STEVE APPS, STATE JOURNAL ARCHIVES STEVE APPS, STATE JOURNAL ARCHIVES STEVE APPS, STATE JOURNAL ARCHIVES Getting your Trinity Audio player ready
There are no active IND applications or FDA-registered human clinical trials for BPC-157
Both peptides are synthetic and intended strictly for in vitro research, analytical purposes, or laboratory-based experimentation
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line
